会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • Methods, Compositions and Kits for High Throughput Kinase Activity Screening Using Mass Spectrometry and Stable Isotopes
    • 使用质谱和稳定同位素进行高通量激酶活性筛选的方法,组合物和试剂盒
    • US20110269161A1
    • 2011-11-03
    • US13078203
    • 2011-04-01
    • Steven P. GygiKazuishi KubotaJudit VillenYonghao Yu
    • Steven P. GygiKazuishi KubotaJudit VillenYonghao Yu
    • C12Q1/48C07K7/08
    • C12Q1/485G01N33/6842G01N33/6848
    • A mass-spectrometry-based method and substrates are provided herein for large scale kinome activity profiling directly from crude lysates using 90 chemically synthesized peptide substrates with amino acid sequences derived from known phosphoproteins. Quantification of peptide phosphorylation rates was achieved via the use of stable isotope labeled synthetic peptides. Half of these peptides immediately or rapidly showed robust and site-specific phosphorylation after incubation with serum-starved HEK293 cell lysate. A method and substrates for obtaining 90 simultaneous activity measurements in a single-reaction format were developed and validated. Activating kinase pathways through insulin or EGF stimulation reproducibly altered the phosphorylation rates of peptides derived from known pathway protein substrates. While examining cell-cycle-specific activities with the panel, a peptide derived from phosphoinositide 3-kinase regulatory subunit demonstrated mitotic and tyrosine-specific phosphorylation, which was confirmed to be a Src kinase site in vivo. The kinome activity profiling strategy was successfully applied with lysates of each of: cells manipulated by various combination of mitogen stimulation, pharmacological perturbation and siRNA-directed kinase knockdown; seven different breast cancer cell lines treated with gefitinib; and each of normal and cancerous tissue samples from renal cell carcinoma patients. This method concurrently measures multiple peptide phosphorylation rates to provide a diagnostic fingerprint pattern for activated kinases, protein phosphatases, modulators of these enzymes, and pathways (kinome) from as little starting material as a few cells.
    • 本文提供基于质谱法的方法和底物,用于使用90个具有源自已知磷蛋白的氨基酸序列的化学合成的肽底物直接从粗裂解物进行大规模活性物质分析。 通过使用稳定同位素标记的合成肽来实现肽磷酸化速率的定量。 与血清饥饿的HEK293细胞裂解物孵育后,这些肽中的一半立即或快速显示出强壮的和位点特异性磷酸化。 开发并验证了用于以单反应形式获得90次同时活动测量的方法和底物。 通过胰岛素或EGF刺激激活激酶途径可重复地改变衍生自已知途径蛋白底物的肽的磷酸化速率。 在使用小组检查细胞周期特异性活性的同时,衍生自磷酸肌醇3-激酶调节亚基的肽表现出有丝分裂和酪氨酸特异性磷酸化,这被证实是体内的Src激酶位点。 激酶活性分析策略成功应用于以下各项的裂解物:由促分裂原刺激,药理学扰动和siRNA定向激酶敲低的各种组合操纵的细胞; 用吉非替尼治疗的七种不同的乳腺癌细胞系; 以及来自肾细胞癌患者的正常和癌组织样本。 该方法同时测量多肽磷酸化速率,以提供活化激酶,蛋白磷酸酶,这些酶的调节剂的诊断指纹图谱,以及与几个细胞一样少的起始材料的途径(kinome)。